Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis

Increasing evidence indicates that endocrine-disrupting chemicals (EDCs) cause a variety of adverse health outcomes and contribute to substantial disease burden. This study summarized the exposure status of polybrominated diphenyl ethers (PBDEs) and phthalates (PAEs) in China and evaluated the disea...

Full description

Bibliographic Details
Main Authors: Hang Wang, Yunhui Zhang
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Toxics
Subjects:
Online Access:https://www.mdpi.com/2305-6304/10/12/766
_version_ 1797455103880331264
author Hang Wang
Yunhui Zhang
author_facet Hang Wang
Yunhui Zhang
author_sort Hang Wang
collection DOAJ
description Increasing evidence indicates that endocrine-disrupting chemicals (EDCs) cause a variety of adverse health outcomes and contribute to substantial disease burden. This study summarized the exposure status of polybrominated diphenyl ethers (PBDEs) and phthalates (PAEs) in China and evaluated the disease burden attributable to PBDEs and PAEs in 2015. The results showed that PBDE and PAE concentrations were higher in coastal areas. The disease burden attributable to PBDEs was 0.77 million cases, and the economic costs were CNY 18.92 billion. Meanwhile, 3.02 million individuals suffered from diseases attributable to PAEs, and the economic costs were CNY 49.20 billion. The economic burden caused by PBDEs and PAEs accounted for 0.28% and 0.72% of China’s Gross Domestic Product (GDP) in 2015, respectively. When comparing China’s results from 2010, it was determined that the GDP ratio of economic costs caused by PAEs in 2015 (0.72%) was lower than in 2010 (1.42%). Finally, compared with the results of the European Union and North America, the GDP ratios of economic costs caused by PAEs in 2015 were 0.19% in Canada (lower than China), 0.29% in the United States (lower than China), and 1.44% in the European Union (higher than China). This study provides important reference values for China’s health governance, and further research should be conducted in the future.
first_indexed 2024-03-09T15:46:44Z
format Article
id doaj.art-75b3b15da4e5423199cdd7eda5fc3f75
institution Directory Open Access Journal
issn 2305-6304
language English
last_indexed 2024-03-09T15:46:44Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Toxics
spelling doaj.art-75b3b15da4e5423199cdd7eda5fc3f752023-11-24T18:25:32ZengMDPI AGToxics2305-63042022-12-01101276610.3390/toxics10120766Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost AnalysisHang Wang0Yunhui Zhang1Key Lab of Health Technology Assessment, National Health Commission of the People’s Republic of China (Fudan University), Shanghai 200032, ChinaKey Lab of Health Technology Assessment, National Health Commission of the People’s Republic of China (Fudan University), Shanghai 200032, ChinaIncreasing evidence indicates that endocrine-disrupting chemicals (EDCs) cause a variety of adverse health outcomes and contribute to substantial disease burden. This study summarized the exposure status of polybrominated diphenyl ethers (PBDEs) and phthalates (PAEs) in China and evaluated the disease burden attributable to PBDEs and PAEs in 2015. The results showed that PBDE and PAE concentrations were higher in coastal areas. The disease burden attributable to PBDEs was 0.77 million cases, and the economic costs were CNY 18.92 billion. Meanwhile, 3.02 million individuals suffered from diseases attributable to PAEs, and the economic costs were CNY 49.20 billion. The economic burden caused by PBDEs and PAEs accounted for 0.28% and 0.72% of China’s Gross Domestic Product (GDP) in 2015, respectively. When comparing China’s results from 2010, it was determined that the GDP ratio of economic costs caused by PAEs in 2015 (0.72%) was lower than in 2010 (1.42%). Finally, compared with the results of the European Union and North America, the GDP ratios of economic costs caused by PAEs in 2015 were 0.19% in Canada (lower than China), 0.29% in the United States (lower than China), and 1.44% in the European Union (higher than China). This study provides important reference values for China’s health governance, and further research should be conducted in the future.https://www.mdpi.com/2305-6304/10/12/766endocrine-disrupting chemicalsChinadisease burdeneconomic costsGross Domestic Product
spellingShingle Hang Wang
Yunhui Zhang
Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis
Toxics
endocrine-disrupting chemicals
China
disease burden
economic costs
Gross Domestic Product
title Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis
title_full Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis
title_fullStr Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis
title_full_unstemmed Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis
title_short Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis
title_sort exposure to polybrominated diphenyl ethers and phthalates in china a disease burden and cost analysis
topic endocrine-disrupting chemicals
China
disease burden
economic costs
Gross Domestic Product
url https://www.mdpi.com/2305-6304/10/12/766
work_keys_str_mv AT hangwang exposuretopolybrominateddiphenylethersandphthalatesinchinaadiseaseburdenandcostanalysis
AT yunhuizhang exposuretopolybrominateddiphenylethersandphthalatesinchinaadiseaseburdenandcostanalysis